D. Farina

1.5k total citations
14 papers, 430 citations indexed

About

D. Farina is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology. According to data from OpenAlex, D. Farina has authored 14 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 4 papers in Rheumatology and 3 papers in Immunology. Recurrent topics in D. Farina's work include Multiple Sclerosis Research Studies (9 papers), Systemic Lupus Erythematosus Research (3 papers) and T-cell and B-cell Immunology (2 papers). D. Farina is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Systemic Lupus Erythematosus Research (3 papers) and T-cell and B-cell Immunology (2 papers). D. Farina collaborates with scholars based in Italy, Malaysia and Switzerland. D. Farina's co-authors include Alessandra Lugaresi, María Trojano, Aldo Quattrone, Francesco Le Pira, Carlo Caltagirone, A. Reggio, Paola Valentino, Simona Bonavita, Giuseppe Salemi and Ugo Nocentini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Archives of Disease in Childhood and Journal of Neuroimmunology.

In The Last Decade

D. Farina

14 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Farina Italy	11	324	98	87	77	62	14	430
Amer Awad United States	7	285 0.9×	127 1.3×	81 0.9×	81 1.1×	52 0.8×	14	430
Valeria Barletta Italy	13	327 1.0×	77 0.8×	70 0.8×	77 1.0×	85 1.4×	30	448
Annalisa Pulizzi Italy	5	285 0.9×	108 1.1×	72 0.8×	82 1.1×	61 1.0×	6	374
M.C. Edo Spain	8	262 0.8×	96 1.0×	81 0.9×	31 0.4×	63 1.0×	10	334
Laura Willis United States	7	305 0.9×	86 0.9×	79 0.9×	54 0.7×	52 0.8×	9	376
Alessandra Mattioda Italy	6	295 0.9×	126 1.3×	45 0.5×	55 0.7×	29 0.5×	6	392
A Calò Italy	7	369 1.1×	162 1.7×	86 1.0×	72 0.9×	133 2.1×	8	557
Wanda Castro-Borrero United States	8	227 0.7×	61 0.6×	56 0.6×	73 0.9×	48 0.8×	12	368
C. T. Bever United States	6	305 0.9×	131 1.3×	58 0.7×	59 0.8×	48 0.8×	6	414
Fabio Brusaferri Italy	4	298 0.9×	193 2.0×	71 0.8×	42 0.5×	53 0.9×	5	370

Countries citing papers authored by D. Farina

Since Specialization

Citations

This map shows the geographic impact of D. Farina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Farina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Farina more than expected).

Fields of papers citing papers by D. Farina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Farina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Farina. The network helps show where D. Farina may publish in the future.

Co-authorship network of co-authors of D. Farina

This figure shows the co-authorship network connecting the top 25 collaborators of D. Farina. A scholar is included among the top collaborators of D. Farina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Farina. D. Farina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Stefano, Vincenzo Di, D. Farina, V. Di Tommaso, et al.. (2020). Data of safety in a single-center alemtuzumab treated population. SHILAP Revista de lepidopterología. 29. 105341–105341. 2 indexed citations

Stefano, Vincenzo Di, D. Farina, V. Di Tommaso, et al.. (2019). Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center. Multiple Sclerosis and Related Disorders. 38. 101504–101504. 22 indexed citations

Farina, D., V. Di Tommaso, D. Travaglini, et al.. (2018). Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis. Multiple Sclerosis Journal. 24(6). 813–815. 11 indexed citations

Borreani, Claudia, Andrea Giordano, Monica Falautano, et al.. (2011). Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS‐Trial. Health Expectations. 17(1). 36–48. 12 indexed citations

Caporale, Christina M., Francesca Notturno, Marta Pace, et al.. (2011). CD1A and CD1E Gene Polymorphisms are Associated with Susceptibility to Multiple Sclerosis. International Journal of Immunopathology and Pharmacology. 24(1). 175–183. 13 indexed citations

Manzoni, Paolo, M. Mostert, Évelyne Jacqz-Aigrain, & D. Farina. (2009). The use of fluconazole in neonatal intensive care units. Archives of Disease in Childhood. 94(12). 983–987. 18 indexed citations

Colosimo, Carlo, Carlo Pozzilli, Marco Frontoni, et al.. (2009). No increase of serum autoantibodies during therapy with recombinant human interferon-β1a in relapsing-remitting multiple sclerosis. Acta Neurologica Scandinavica. 96(6). 372–374. 10 indexed citations

Nocentini, Ugo, Patrizio Pasqualetti, Simona Bonavita, et al.. (2005). Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 12(1). 77–87. 97 indexed citations

Savettieri, Giovanni, Demetrio Messina, Virginia Andreoli, et al.. (2004). Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. Journal of Neurology. 251(10). 1208–1214. 139 indexed citations

10.

Muraro, Paolo A., Laura Bonanni, Andrea Pantalone, et al.. (2004). Decreased integrin gene expression in patients with MS responding to interferon-β treatment. Journal of Neuroimmunology. 150(1-2). 123–131. 34 indexed citations

11.

Ensoli, Fabrizio, Valeria Fiorelli, Alessandra Lugaresi, et al.. (2002). Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors α and β, and interferon γ. Multiple Sclerosis Journal. 8(4). 284–288. 23 indexed citations

12.

Lugaresi, Alessandra, Christina M. Caporale, D. Farina, et al.. (2001). Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis. Neurological Sciences. 22(2). 209–210. 20 indexed citations

13.

Giugni, Elisabetta, Carlo Pozzilli, Stefano Bastianello, et al.. (1997). MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 3(4). 221–225. 28 indexed citations

14.

Farina, D., et al.. (1991). Long-term influence of dialysis treatment on beta 2-microglobulin, interleukin-2 R and tumour necrosis factor.. PubMed. 6 Suppl 2. 61–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact